Linda Liverani

Dr. Linda Liverani

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2026 in Neurospine
Verified
Journal Article
Open access
DADaniyal Ashraf
Daniyal Ashraf
VSVivek Sanker
Vivek Sanker
LLLinda Liverani
Linda Liverani
CPChelsea Park
Chelsea Park
RMRavi Teja Medikonda
Ravi Teja Medikonda
ADAtman Desai
Atman Desai
Spine imaging represents a complex diagnostic frontier characterized by anatomical variability, motion artifacts, metallic instrumentation interference, and significant inter-reader diagnostic variability (κ=0.20 across institutions). While conventional discriminative artificial intelligence (AI) models achieve >95% accuracy in detecting degenerative changes, they remain limited by data scarcity, heterogeneous protocols, and poor generalizability. In the spine, these limitations are particularly relevant because clinical decisions can often depend on subtle distinctions (such as differentiating levels of canal or foraminal stenosis, characterizing Modic endplate changes, or assessing pedicle and vertebral morphology), where small inconsistencies can meaningfully alter management or surgical planning. Generative AI (GenAI) systems—including generative adversarial networks (GANs), diffusion models, and vision-language models (VLMs)—offer a paradigm shift by learning underlying data structures to generate high-quality synthetic outputs rather than merely classifying existing data. This narrative review, conducted using SANRA (scale for the assessment of narrative review articles) methodology across PubMed, Scopus, Embase, and Cochrane Library, examined GenAI applications in spine imaging. Eligible studies included observational designs through randomized controlled trials exploring image reconstruction, synthetic computed tomography (CT) generation, segmentation, and surgical planning applications. GAN-generated synthetic magnetic resonance imaging sequences reduce scan times by ~40% while maintaining diagnostic confidence; diffusion models enable radiation-free synthetic CT for preoperative planning; and VLMs generate structured radiology reports with hallucination rates <1.12%. However, critical barriers impede clinical translation: external validation gaps reveal AI performance collapse in real-world cohorts (sensitivity drops to 54.9% in cervical fracture detection); hallucinations and anatomical inaccuracies risk misguiding implant sizing; bias amplification magnifies demographic underrepresentation; and fragmented, small datasets lack standardized benchmarks. Technical fragility, computational demands, clinician trust deficits, and unresolved regulatory frameworks for iteratively-updating systems remain unaddressed. Successful integration requires coordinated development across 5 priorities: (1) multi-institutional datasets with cross-vendor harmonization, (2) federated learning frameworks preserving privacy, (3) uncertainty quantification and explainability tools, (4) outcome-linked clinical validation replacing technical metrics, and (5) workflow-integrated systems with DICOM-native interfaces and provenance tracking.

1 March 2026 in Journal of Spine Surgery
Verified
Journal Article
Open access
PDF file
VSVivek Sanker
Vivek Sanker
SGSawsane Ghaddar
Sawsane Ghaddar
AAAnam Sayed Mushir Ali
Anam Sayed Mushir Ali
GGGokulesh D. Gurumurthy
Gokulesh D. Gurumurthy
MJMalavika Jayan
Malavika Jayan
ADAtman Desai
Atman Desai
Review Article Sacral chordomas: surgical management, reconstruction, and translational advances: a systematic review Vivek Sanker, Sawsane Ghaddar, Anam Sayed Mushir Ali, Gokulesh D. Gurumurthy, Malavika Jayan, Mahin Qudeer Sheikh, Linda Liverani, Gayathri Sunil, Sunil Kumar, Maria Jose Cavagnaro, Ravi Medikonda, John Ratliff, Atman Desai

18 September 2026 in Neurosurgery
Verified
Journal Article
Closed access
SVSilvia D. Vaca
Silvia D. Vaca
JKJose Kuzli
Jose Kuzli
LLLinda Liverani
Linda Liverani
LRLucia Rivera-Lara
Lucia Rivera-Lara
PMPablo Maidana
Pablo Maidana
NPNirav J. Patel
Nirav J. Patel
BACKGROUND AND OBJECTIVES: Short-term global neurosurgical missions and off-site fellowships rarely achieve durable independence in low-resource settings. Sustainable capacity building requires longitudinal, locally embedded training that integrates technical skill with system development. The objective of this study was to evaluate whether a locally embedded “Fellowship at Home” model could establish sustainable independent cerebrovascular surgical capacity and identify factors associated with success. METHODS: We established a longitudinal partnership (2022-present) between Brigham and Women's Hospital and Hospital de Itauguá in Paraguay to develop a comprehensive cerebrovascular program through a model termed “Fellowship at Home.” The goal was independent, safe practice. The program combines iterative in-country microsurgical training, development of neuroanesthesia and neurocritical care, and implementation of standardized operative and perioperative systems, reinforced by continuous virtual mentorship. A defining strategy was deliberate focus on a single high-complexity “anchor pathology.” Brain arteriovenous malformations were selected because their safe treatment requires the full integration of advanced anesthesia, microsurgery, imaging, operative technology, and critical care. RESULTS: Over 3 years, 18 brain arteriovenous malformation (bAVM) resections were performed collaboratively without preoperative embolization, of which 13 were Spetzler-Martin grade II to IV. This resulted in transition to independent practice, with 14 bAVMs subsequently resected by the local neurosurgeon, of which 4 were Spetzler-Martin grade III to IV. Systems built to support bAVM care translated across the local program, with aneurysm clipping volume increasing from 100 cases by 2025. CONCLUSION: Focusing on a single complex “anchor pathology” can serve as a catalyst for system-wide capability building. The Fellowship at Home model demonstrates that durable, high-level neurosurgical capacity in low- and middle-income countries can be achieved through continuity, co-ownership, and embedded training. Analysis of this partnership identified recurring determinants of success, including local leadership, longitudinal mentorship, multidisciplinary systems development, and progressive operative autonomy, which may inform future capacity-building initiatives.

15 June 2026 in Clinical Neuroradiology
Verified
Journal Article
Closed access
ADAllison K. Duh
Allison K. Duh
LTLydia T. Tam
Lydia T. Tam
LLLinda Liverani
Linda Liverani
NNNathan N. Ng
Nathan N. Ng
EMEmily S. McKenna
Emily S. McKenna
NFNils D. Forkert
Nils D. Forkert

16 September 2026 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
MTMariam Tolba
Mariam Tolba
MZMichael Zhang
Michael Zhang
JDJonathan K. Duh
Jonathan K. Duh
LLLinda Liverani
Linda Liverani
JCJulia Chang
Julia Chang
KYKristen W. Yeom
Kristen W. Yeom

1 June 2026 in Journal of Spine Surgery
Verified
Journal Article
Open access
PDF file
VSVivek Sanker
Vivek Sanker
ENEmil O. R. Nordin
Emil O. R. Nordin
AAAnam Sayed Mushir Ali
Anam Sayed Mushir Ali
GGGokulesh D. Gurumurthy
Gokulesh D. Gurumurthy
ATAlexander Thaller
Alexander Thaller
ADAtman Desai
Atman Desai
Background: Spinal metastases (SMs) are common, debilitating, and often associated with severe pain and neurologic disability. Treatment decisions hinge on anticipated life expectancy, yet survival and recurrence outcomes remain poorly defined across primary tumor types. This study is to systematically review and meta-analyze outcomes of SM stratified by primary cancer, with focus on survival, recurrence, and treatment patterns. Methods: PubMed, Scopus, Web of Science Core Collection, and Embase (Ovid) were searched from inception to April 16, 2025. Eligible studies reported outcomes in patients with SM from any primary tumor. Random-effects meta-analyses were performed for survival and recurrence. Study quality was assessed with ROBINS-I. Results: One hundred twenty-three studies (38,780 patients) across nine primary tumors were included; 61 studies (9,222 patients) contributed to meta-analysis. Lung cancer accounted for the largest cohort (n=26,918), followed by gynecologic (n=3,679), breast (n=1,961), and renal (n=1,732). Pooled 1-year survival ranged from 46% in lung SM to 74% in prostate SM. Median survival was shortest for liver (8.2 months) and lung (12.1 months), and longest for thyroid (59.9 months) and melanoma (57.9 months). Recurrence rates were consistently low (<5%), though thyroid SM carried a slightly higher long-term risk. Conclusions: Outcomes in SMs are strongly influenced by primary tumor biology. These data provide benchmarks for clinical decision-making and highlight the need for prospective studies integrating molecular and functional outcomes.